Similar Efficacy and Lower Cost Associated With Ceftazidime Compared to Tobramycin Coupled With Vancomycin in Antibiotic Spacers in the Treatment of Periprosthetic Joint Infection
- 16 April 2024
- journal article
- conference paper
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 39 (8) , S323-S327
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Balanced, Stemmed, and Augmented Articulating Total Knee Spacer TechniqueArthroplasty Today, 2020
- Improving Value in Total Joint Arthroplasty: A Comprehensive Patient Education and Management Program Decreases Discharge to Post-Acute Care Facilities and Post-Operative ComplicationsThe Journal of Arthroplasty, 2018
- Infection burden in total hip and knee arthroplasties: an international registry-based perspectiveArthroplasty Today, 2017
- Improving value in primary total joint arthroplasty care pathways: changes in inpatient physical therapy staffingArthroplasty Today, 2017
- The results of two‐stage revision TKA using Ceftazidime–Vancomycin‐impregnated cement articulating spacers in Tsukayama Type II periprosthetic joint infectionsKnee Surgery, Sports Traumatology, Arthroscopy, 2015
- Two-Stage Arthroplasty for Prosthetic Joint InfectionThe Journal of Arthroplasty, 2013
- Value-Based Healthcare and Orthopaedic Surgery: Editorial CommentClinical Orthopaedics and Related Research, 2012
- Incidence of Prosthetic Joint Infections After Primary Knee ArthroplastyThe Journal of Arthroplasty, 2010
- Prosthetic Joint Infection Risk After Total Hip Arthroplasty in the Medicare PopulationThe Journal of Arthroplasty, 2009
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987